7Baggers
 Published on: 2025-10-03 04:12:25  newser.com Fri, 03 Oct 2025 09:12:25 GMT
 Published on: 2025-10-03 03:10:59  newser.com Fri, 03 Oct 2025 08:10:59 GMT
 Published on: 2025-10-02 22:11:46  newser.com Fri, 03 Oct 2025 03:11:46 GMT
 SELLAS Life Sciences to host virtual R&D day on AML treatments  Investing.com Nigeria Wed, 01 Oct 2025 06:35:59 GMT
 sellas life sciences to host virtual r&d day on aml treatments  Investing.com UK Tue, 30 Sep 2025 12:38:00 GMT
 Published on: 2025-09-30 01:16:34  newser.com Tue, 30 Sep 2025 06:16:34 GMT
 Published on: 2025-09-29 11:38:19  newser.com Mon, 29 Sep 2025 16:38:19 GMT
 Published on: 2025-09-29 09:42:54  newser.com Mon, 29 Sep 2025 14:42:54 GMT
 Multi factor analysis applied to SELLAS Life Sciences Group Inc.  newser.com Sat, 27 Sep 2025 17:22:15 GMT
 SELLAS Life Sciences Group Announces Exercise of Existing  GlobeNewswire Thu, 11 Sep 2025 07:00:00 GMT
 SELLAS Life Sciences’ Recent Warrant Inducement Agreement  TipRanks Thu, 11 Sep 2025 07:00:00 GMT
 sellas life sciences to receive $23.6 million from exercise of warrants  MarketScreener Thu, 11 Sep 2025 07:00:00 GMT
 published on: 2025-09-08 15:44:09  beatles.ru Mon, 08 Sep 2025 12:45:30 GMT
 published on: 2025-09-03 12:34:30  Newser Mon, 01 Sep 2025 18:32:17 GMT
 published on: 2025-08-31 02:39:36  Newser Sun, 31 Aug 2025 07:39:36 GMT
 published on: 2025-09-02 23:33:47  Newser Sun, 31 Aug 2025 06:00:33 GMT
 published on: 2025-08-30 17:25:25  Newser Sat, 30 Aug 2025 22:25:25 GMT
 published on: 2025-08-29 15:06:50  Newser Fri, 29 Aug 2025 20:06:50 GMT
 published on: 2025-08-29 02:50:59  Newser Fri, 29 Aug 2025 07:50:59 GMT
 published on: 2025-08-28 22:22:08  Newser Fri, 29 Aug 2025 03:22:08 GMT
 SELLAS Life Sciences’ Triumphant Advances  StocksToTrade Wed, 20 Aug 2025 07:00:00 GMT
 published on: 2025-08-15 06:21:10  beatles.ru Fri, 15 Aug 2025 03:21:27 GMT
 sellas life sciences reports q2 2025 financial results  TipRanks Wed, 13 Aug 2025 04:35:32 GMT
 Sellas Life Sciences Reports Q2 2025 Financial Results  TipRanks Tue, 12 Aug 2025 07:00:00 GMT

SELLAS Life Sciences Group, Inc
(NASDAQ:SLS) 

SLS stock logo

SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a wilms tumor 1 targeting peptide-based cancer immun...

Full Time Employees: 5
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends